Skip to content
OpenCapital
Get started

DocGo DCGO Cumulative Gross Losses and Impairments

Cumulative Gross Losses and Impairments at other companies

SRT
Strata Critical Medical, Inc. Class A Common StockSRTA
$1K-99.5%

Segments

By segment

See full
Corporate$0—
Mobile Health Services$0—
Transportation Services$0—

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%—
Net margin-62.2%—
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%—
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's cumulative gross losses and impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's cumulative gross losses and impairments?
DocGo (DCGO) reported cumulative gross losses and impairments of $0 in Q1 2026.
What is the long-term trend for DocGo's cumulative gross losses and impairments?
Over 2 years (2022 to 2025), DocGo's cumulative gross losses and impairments has grown at a 346.4% compound annual growth rate (CAGR), from $2.92M to $58.23M.
What does cumulative gross losses and impairments mean?
This metric aggregates all unrealized losses and recognized impairment charges on investment securities that have not yet been realized through a sale. It provides a comprehensive view of the negative valuation adjustments impacting the bank's equity. It is a key indicator of the credit and market risk embedded in the bank's long-term holdings.